NASDAQ: CORT · Health Care / Biotechnology: Pharmaceutical Preparations

Corcept Therapeutics Incorporated

How Corcept Therapeutics Incorporated compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$9.3B

Price

$85.95

P/E

168.4

EPS (TTM)

$0.51

1-year return

19.3%

Dividend yield

0.0%

52-week range

$75.05–$121.19

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources